Study to Assess Prevalence of BRCA1 and BRCA2 Mutation Among Ovarian, Primary Peritoneal and Fallopian Tube Cancer Patients in India
- Status
- COMPLETED
- Phase
- N/A
Clinical Trials Related to Ovarian Cancer
Related studies linked through entity extraction aliases.
Olaparib After Response to Trabectedin-pegylated Liposomal Doxorubicin in Recurrent Ovarian Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Decision Support for BRCA Testing in Ethnically Diverse Women
- Status
- COMPLETED
- Phase
- NA
Enzalutamide in Metastatic or Advanced Non-resectable Granulosa Cell Ovarian Tumors: GREKO III Study
- Status
- COMPLETED
- Phase
- PHASE2
CPI-006 Alone and in Combination With Ciforadenant and With Pembrolizumab for Patients With Advanced Cancers
- Status
- COMPLETED
- Phase
- PHASE1
Sentinel Lymph Node in Early Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE2
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Status
- RECRUITING
- Phase
- N/A
Comparative Effectiveness of HIPEC Following Interval Debulking Surgery in Patients With Advanced-stage Ovarian Cancer
- Status
- UNKNOWN
- Phase
- NA
An Observational Study of Combination of Pegylated Liposomal Doxorubicin and Trabectedin in Routine Practice in Patients With Recurrent Partial-platinum Sensitive Ovarian Cancer
- Status
- UNKNOWN
- Phase
- N/A
Trial of Pembrolizumab Following Weekly Paclitaxel for Platinum-resistant Ovarian, Fallopian Tube or Peritoneal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Phase I Dose-escalation Study of Subcutaneous ALM201 in Patients With Advanced Ovarian Cancer and Other Solid Tumours
- Status
- TERMINATED
- Phase
- PHASE1
A Study of Prexasertib (LY2606368) in Platinum-Resistant or Refractory Recurrent Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Administration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors Reactive Against Neoantigens in People With Metastatic Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Pembrolizumab With Chemotherapy in Front Line Advanced Ovarian, Primary Peritoneal and Fallopian Tube Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Clinical Impact of Dedicated MR Staging of Ovarian Cancer
- Status
- UNKNOWN
- Phase
- NA
A Study of DKN-01 as a Monotherapy or in Combination With Paclitaxel in Patients With Recurrent Epithelial Endometrial or Epithelial Ovarian Cancer or Carcinosarcoma
- Status
- COMPLETED
- Phase
- PHASE2
Atezolizumab With Neoadjuvant Chemotherapy for Patients With Newly-Diagnosed Advanced-Stage Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Intervention of Ovarian Cancer With Antigen-specific Engineered Immune Effectors
- Status
- ENROLLING_BY_INVITATION
- Phase
- PHASE1/PHASE2
A Study of Apatinib Treatment in for Advanced Ovarian Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
IMX-110 in Patients With Advanced Solid Tumors
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2